YOUR BUSINESS AUTHORITY
Springfield, MO
St. Louis biotechnology startup Wugen Inc. raised $172 million in a funding round.
The company plans to use the funds to advance clinical development of its cancer-fighting therapies, the St. Louis Business Journal reports.
The startup has raised more than $200 million to date.
Read more from the St. Louis Business Journal.
A City Utilities employee since 2017 with a 25-year legal background, he now leads the municipal utility provider with an $895 million annual budget.
City employee dies in landfill accident
LORE names members, raises $430K
Spring 2025 Architects & Engineers Project Report
Kehoe appoints 3 locals to state boards, commission
Financial consulting, investment firm Ozarks Capital debuts
Letter to the Editor: These candidates embody unity, collaboration, independence